Immunomodulatory therapy with tumour necrosis factor α inhibitors in children with antinuclear antibody-associated chronic anterior uveitis: long-term results

Doycheva, Deshka; Zierhut, Manfred; Blumenstock, Gunnar; Stuebiger, Nicole; Januschowski, Kai; Voykov, Bogomil; Deuter, Christoph
April 2014
British Journal of Ophthalmology;Apr2014, Vol. 98 Issue 4, p523
Academic Journal
Aim The aim of the study was to assess the long-term efficacy and tolerability of tumour necrosis factor α (TNFα) inhibitors in the therapy of children with refractory antinuclear antibody (ANA)-associated chronic anterior uveitis. Methods Retrospective analysis of 31 children with ANA-associated uveitis, treated with TNFα inhibitors with a follow-up period of at least 2 years. The outcome measures included: control of inflammation, corticosteroid-sparing potential and side effects. Results Twenty-three children (74%) were treated with adalimumab, five children (16%) with infliximab and three children (10%) with etanercept. Control of uveitis, defined as 0 anterior chamber cells while on ⩽2 drops/ day topical corticosteroids, was achieved in 22 of 31 patients (71%) after 1 year (95% CI 52% to 86%), and in 21 of 29 patients (72%) after 2 years of treatment (95% CI 53% to 87%). Control of uveitis was observed in 18 of 23 children (78%) treated with adalimumab, and in two of five children (40%) treated with infliximab. In all children treated with etanercept, no sufficient inflammatory control was found. Systemic corticosteroids could be discontinued in 71% (12/17 children) and topical corticosteroids in 55% (17/31) of the patients. Treatment-related side effects were found in nine children (29%, rate: 0.10/patient-year). Conclusions Our data show that adalimumab and infliximab have beneficial effects in the therapy of severe ANA-associated anterior uveitis in children.


Related Articles

  • Managing posterior uveitis in children a must. Rajecki, Ron // Ophthalmology Times;11/15/2008, Vol. 33 Issue 22, p1 

    The article reports that the Moorfields Eye Hospital's Susan Lightman advised ophthalmologists on the necessity of adequately treating pediatric posterior uveitis even though the condition can be difficult to manage in children. Lightman made the recommendation during the World Ophthalmology...

  • Pseudotumor Blepharon. Sethi, Sumita; Meel, Rachna; Mehta, Mridula; Ghose, Supriyo // Journal of Pediatric Ophthalmology & Strabismus;Sep/Oct2011, Vol. 48 Issue 5, p266 

    A photo quiz about a five-year-old boy who developed total ankyloblepharon on his left eye and cystic swelling in the upper eyelid is presented.

  • Use of Biologic Agents in The Treatment of Uveitis. Pasadhika, Sirichai; Suhler, Eric B.; Cunningham Jr., Emmett T. // Review of Ophthalmology;Jan2010, Vol. 17 Issue 1, p46 

    The article discusses the use of biologic response modifiers or biologic agents as new medication for uveitis or ocular inflammatory diseases. An overview of the U.S. Food and Drug Administration approved biologic drugs and tumor necrosis factor (TNF) blocker including Infliximab, Etanercept,...

  • New treatments in Noninfectious Uveitis. E. Miserocchi, G. Modorati, C. S. Foster. Developments in Ophthalmology Vol. 51. Baartman, Brandon; Kurup, Shree // Graefe's Archive of Clinical & Experimental Ophthalmology;Feb2013, Vol. 251 Issue 2, p623 

    No abstract available.

  • Involvement of an ICE-like protease in Fas-mediated apoptosis. Enari, Masato; Hug, Hubert // Nature;5/4/1995, Vol. 375 Issue 6526, p78 

    Reports that expression of crmA inhibits cytotoxicity induced by anti-Fas antibody or tumor necrosis factor. Suggestion on involvement of an ICE-like (interleukin-1beta-converting enzyme) protease in Fas-mediated apoptosis and TNF-induced cytotoxicity.

  • CITATIONS AND CLINICIANS' NOTES: OPHTHALMOLOGY.  // Current Medical Literature: Pediatrics;2004, Vol. 17 Issue 1, p14 

    Presents information on several studies about pediatric ophthalmology. "Long-Term Results of Frontalis Suspension Using Autogenous Fascia Lata for Congenital Ptosis in Children Under 3 Years of Age," by I. Leibovitch et al; "Ocular-Hypertensive and Anti-Inflammatory Response to Rimexolone...

  • Effect of Intracameral Cefuroxime on Fibrinous Uveitis After Pediatric Cataract Surgery. Gradin, Dan; Mundia, Daniel // Journal of Pediatric Ophthalmology & Strabismus;Jan/Feb2011, Vol. 48 Issue 1, p45 

    Purpose: To determine whether intracameral cefuroxime reduces postoperative fibrin formation after pediatric cataract surgery. Methods: Children aged 3 months to 10 years with bilateral congenital or developmental cataracts who underwent surgery between February and July 2008 were eligible for...

  • Uveitis in Childhood. Kadayifçilar, Sibel; Eldem, Bora; Tumer, Burak // Journal of Pediatric Ophthalmology & Strabismus;Nov/Dec2003, Vol. 40 Issue 6, p335 

    Purpose: To review the etiologic factors and complications of uveitis in patients younger than 16 years. Patients and Methods: Between January 1989 and December 1999 in the Department of Ophthalmology of Hacettepe University School of Medicine, 219 patients were diagnosed or observed as having...

  • Exclusion of Students With Conjunctivitis From School: Policies of State Departments of Health. Ohnsman, Christina M. // Journal of Pediatric Ophthalmology & Strabismus;Mar/Apr2007, Vol. 44 Issue 2, p101 

    Purpose: To use current state department of health regulations regarding exclusion of students with conjunctivitis from school as a starting point in developing uniform recommendations for schools. Methods: State departments of health were asked to state their policy regarding when a child with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics